BridgeBio Pharma, Inc.
Pharmaceutical company · Palo Alto, California, United States · Nasdaq: BBIO
BridgeBio Pharma, Inc. is a pharmaceutical company headquartered in Palo Alto, California, United States. Its shares trade on Nasdaq under the ticker BBIO.
Profile compiled from public records. Is this your company? Request a correction or update
BridgeBio Pharma at a glance
Typepharmaceutical company
HeadquartersPalo Alto, California, United States
Stock listingNasdaq: BBIO
SEC industryPharmaceutical Preparations
SEC CIK1743881
Frequently asked questions about BridgeBio Pharma
Where is BridgeBio Pharma headquartered?
BridgeBio Pharma, Inc. is headquartered in Palo Alto, California, United States.
What does BridgeBio Pharma do?
BridgeBio Pharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is BridgeBio Pharma a public company?
Yes. BridgeBio Pharma, Inc. trades on Nasdaq under the ticker BBIO.
Similar companies
- Semnur Pharmaceuticals, Inc.Palo Alto, California, United States
- TheRas, Inc.Palo Alto, California, United States
- Evommune, Inc.Palo Alto, California, United States
- Anacor Pharmaceuticals, Inc.Palo Alto, California, United States
- Vincerx Pharma, Inc.Palo Alto, California, United States
- Capacity Bio, Inc.Palo Alto, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences